Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

被引:764
作者
Whitmer, RA [1 ]
Gunderson, EP
Barrett-Connor, E
Quesenberry, CP
Yaffe, K
机构
[1] Kaiser Permanente, Div Res, Oakland, CA 94612 USA
[2] Univ Calif, Dept Epidemiol, La Jolla, CA USA
[3] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
来源
BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 330卷 / 7504期
关键词
D O I
10.1136/bmj.38446.466238.E0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life. Design Analysis of prospective data from a multiethnic population based cohort. Setting Kaiser Permanente Northern California Medical Group, a healthcare delivery organisation. Participants 10 276 men and women who underwent detailed health evaluations from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994. Main outcome measures Diagnosis of dementia from January 1994 to April 2003. Time to diagnosis was analysed with Cox proportional hazard models adjusted for age, sex, race, education, smoking, alcohol use, marital status, diabetes, hypertension, hyperlipidaemia, stroke, and ischaemic heart disease. Results Dementia was diagnosed in 713 (6.9%) participants. Obese people (body mass index >= 30) had a 74% increased risk of dementia (hazard ratio 1.74, 95% confidence interval 1.34 to 2.26), while overweight people (body mass index 25.0-29.9) had a 35% greater risk of dementia (1.35, 1.14 to 1.60) compared with those of normal weight (body mass index 18.6-24.9). Compared with those in the lowest fifth, men and women in the highest fifth of the distribution of subscapular or tricep skinfold thickness had a 72% and 59% greater risk of dementia, respectively (1.72, 1.36 to 2.18, and 1.59, 1.24 to 2.04). Conclusions Obesity in middle age increases the risk of future dementia independently of comorbid conditions.
引用
收藏
页码:1360 / 1362B
页数:6
相关论文
共 38 条
[1]   Midlife adiposity and the future risk of Parkinson's disease [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Nelson, JS ;
Masaki, KH ;
Tanner, CM ;
Curb, JD ;
Blanchette, PL ;
Popper, JS ;
Petrovitch, H .
NEUROLOGY, 2002, 59 (07) :1051-1057
[2]   THE CALIFORNIA AUTOMATED MORTALITY LINKAGE SYSTEM (CAMLIS) [J].
ARELLANO, MG ;
PETERSEN, GR ;
PETITTI, DB ;
SMITH, RE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1984, 74 (12) :1324-1330
[3]  
Barrett-Connor E, 1998, J Nutr Health Aging, V2, P113
[4]   HUMAN-BODY COMPOSITION AND THE EPIDEMIOLOGY OF CHRONIC DISEASE [J].
BAUMGARTNER, RN ;
HEYMSFIELD, SB ;
ROCHE, AF .
OBESITY RESEARCH, 1995, 3 (01) :73-95
[5]   Obesity is a chronic, relapsing neurochemical disease [J].
Bray, GA .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (01) :34-38
[6]   Vascular involvement in cognitive decline and dementia - Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study [J].
Breteler, MMB .
VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 :457-465
[7]  
Brookmeyer R, 2000, STAT MED, V19, P1481, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO
[8]  
2-U
[9]   Nutritional reversion of cognitive impairment in the elderly [J].
Bunout, D ;
Fjeld, C .
NUTRITION AND BRAIN, 2001, 5 :263-281
[10]   Adipobiology of disease: Adipokines and adipokine-targeted pharmacology [J].
Chaldakov, GN ;
Stankulov, IS ;
Hristova, M ;
Ghenev, PI .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (12) :1023-1031